Bone Marrow Failure Disorders

Explore clinical trials studying Bone Marrow Failure Disorders. Study availability and eligibility vary by location and protocol.

297 public trials 61 recruiting studies

Refine in advanced search Browse all conditions

Bone Marrow Failure Disorders trial results

Active, Not Recruiting

Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy

NCT02979873

Conditions: Anemia, Anemia, Aplastic, Bone Marrow Diseases, +4 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Active, Not Recruiting

ATGAM General Investigation

NCT06039020

Conditions: Anemia, Anemia, Aplastic, Aplastic Anemia, +4 more
Locations: Pfizer Tokyo, Japan

View Trial Details

Active, Not Recruiting

Long Term Follow-up Observational Study After Clinical Trials of AMG531 (Romiplostim) in Patients With Untreated Aplastic Anemia

NCT04870346

Conditions: Anemia, Anemia, Aplastic, Aplastic Anemia, +4 more
Locations: Kanazawa University, College of Medical Pharmaceutical and Health Sciences, School of Medicine, Department of Hematology Kanazawa, Ishikawa-ken, Japan

View Trial Details

Active, Not Recruiting

Multi-omics Profiling of Patients With Aplastic Anemia Before and After CD7-CAR-T Therapy

NCT07139600

Conditions: Anemia, Anemia, Aplastic, Aplastic Anaemia, +6 more
Locations: Xuzhou Medical University Xuzhou, Jiangsu, China

View Trial Details

Active, Not Recruiting

Eltrombopag for People With Fanconi Anemia

NCT03206086

Conditions: Anemia, Anemia, Aplastic, Anemia, Hypoplastic, Congenital, +16 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Active, Not Recruiting

Cyclophosphamide Added to Standard Immunosuppressive Therapy With Herombopag as Front-line Therapy in Patients With Severe Aplastic Anemia

NCT05975996

Conditions: Anemia, Anemia, Aplastic, Bone Marrow Diseases, +4 more
Locations: Regenerative Medicine Center Tianjin, Tianjin Municipality, China

View Trial Details

Active, Not Recruiting

Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant

NCT03301168

Conditions: Acute Lymphoblastic Leukemia, Anemia, Anemia, Aplastic, +34 more
Locations: Children's Hospital Los Angeles Los Angeles, California, United States

Stanford University - Division of Pediatric Stem Cell Transplant & Regenerative Medicine Palo Alto, California, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

Children's Healthcare of Atlanta Atlanta, Georgia, United States

View Trial Details

Bone Marrow Failure Disorders

Bone Marrow Failure Disorders trial results

Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy

ATGAM General Investigation

Long Term Follow-up Observational Study After Clinical Trials of AMG531 (Romiplostim) in Patients With Untreated Aplastic Anemia

Multi-omics Profiling of Patients With Aplastic Anemia Before and After CD7-CAR-T Therapy

Eltrombopag for People With Fanconi Anemia

Cyclophosphamide Added to Standard Immunosuppressive Therapy With Herombopag as Front-line Therapy in Patients With Severe Aplastic Anemia

Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant

Related conditions